Business
Endonovo Therapeutics Signs Distribution Agreement with Plagens Medical Consultants for its Pain Relief Electroceutical™ SofPulse®
Endonovo Therapeutics Signs Distribution Agreement with Plagens Medical Consultants for its Pain Relief Electroceutical™ SofPulse®.
About this update from Endonovo Therapeutics, Inc.
[{"type":"text","content":"\nLOS ANGELES, CA, May 09, 2018 (GLOBE NEWSWIRE) --  Endonovo Therapeutics, Inc. (OTCQB: ENDV) (\"Endonovo\" or the \"Company\"), a commercial-stage developer of Electroceutical™ Therapies, today announced a distribution agreement with Plagens Medical Consultants for the distribution of  SofPulse™, its non-invasive Electroceutical™ Therapy for post-operative pain relief and reduction of swelling. \n SofPulse™ is the Company's FDA-Cleared Electroceutical™ System for the palliative treatment of post-operative pain and edema in superficial soft tissues. SofPulse™ is an easy-to-place, non-invasive device delivering targeted MicroCurrent Therapy (tMCT) to enhance post-surgical recovery. tMCT is an innovative process using proprietary technology to reduce pain and swelling. The therapy is non-invasive and non-pharmacologic, with no known side effects and no potential for overdose or dependency. SofPulse™ has been used effectively and studied extensively in soft tissue post-operative management. The low levels of microcurrent are completely safe and, in fact, are 1000 times lower than those emitted by a mobile phone. The Company's Electroceutical™ Therapy has been evaluated in 5 randomized, double-blind controlled clinical trials demonstrating: 300% decrease in mean pain scores at 5 hours post-surgery;2.2-fold reduction in narcotic use post-surgery in active users; and 275% lower mean IL-1 beta (inflammatory biomarker) in the wound exudates of active users following surgery Endonovo's non-invasive pain relief therapy, SofPulse®, represents a low-cost, drug free solution to the over use of opioids following surgical procedures. Following surgery, many patients will head home with prescriptions for 30 or more opioid painkillers, which is enough to trigger addiction. However, the American Society of Anesthesiologists recommends using prescription painkillers sparingly, if at all, after surgery. Post-surgical prescription practices have played a role in the opioid epidemic and despite the risk of dependence, many surgery patients receive opioid prescriptions for a month's supply or more. Furthermore, about 6 percent of surgery patients are still using opioid painkillers three months or longer after their surgery, according to a study publ...